Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV2 in HPV-associated Cervical Lesions
NCT02346227Phase 3Completed
- Start
- Jan 2015
- Primary completion
- Aug 2018
- Modality
- Implantable Devices, Transdermal Patches, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of AV2 in cervical dysplasia (CIN), human papillomavirus infection. Started Jan 2015; status: completed.
02
Drugs
AV2
03
Conditions
cervical dysplasia (CIN)human papillomavirus infection
Beyond the preview
Go deeper on NCT02346227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02346227.